Hemopure is a hematological drug used to treat anemia, a condition in which the body does not produce enough red blood cells. It is a synthetic, oxygen-carrying blood substitute that is made from bovine hemoglobin. Hemopure is administered intravenously and is used to treat anemia in patients who are not able to receive a blood transfusion. It is also used to treat anemia in patients who are at risk of developing complications from a blood transfusion.
The Hemopure market is composed of pharmaceutical companies that produce and distribute the drug. These companies are focused on developing and marketing Hemopure for the treatment of anemia. They are also involved in research and development of new formulations of the drug.
Some companies in the Hemopure market include Biopure Corporation, Baxter International, and Grifols. Show Less Read more
